16 results
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
or environmental safety of new chemical or biological substances. Non-clinical (pharmaco-toxicological) studies must be conducted in compliance with the principles … of the jurisdictions in which we operate, including, without limitation, employment, foreign corrupt practices, trade restrictions and sanctions, environmental
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
, without limitation, employment, foreign corrupt practices, trade restrictions and sanctions, environmental, competition, and patient privacy and other
S-1/A
EX-1.1
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
it is a party.
(jj) Certain Environmental Matters. (i) The Company and its subsidiaries (x) are in compliance with all, and have not violated any … or toxic substances or wastes, pollutants or contaminants (collectively, “Environmental Laws”); (y) have received and are in compliance with all
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
operate, including, without limitation, employment, foreign corrupt practices, trade restrictions and sanctions, environmental, competition, and patient
S-1
EX-2.2
33rh77v ck
25 Aug 23
IPO registration
5:03pm
S-1
xwj8mo
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.1
ewo1l 5wtmyayidlj
25 Aug 23
IPO registration
5:03pm
DRS/A
zvpc1zv9pvs
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
ka957l wjn
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
pnc6uo rvnm7
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
o8zcdwvrn512gl
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
jwceb
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
g7mqosu6w2i
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
7lcf 27o7mx
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
doigv3voq0jaevc69
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next